Stefan Wouters
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stefan Wouters has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Albert Ludolph
University of Ulm, Neurology Clinic, Ulm, Germany
2 shared publications- Anna Månberg
Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
2 shared publications Anna Szczepińska
Department of Clinical Neuroscience, Karolinska Institute, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden
2 shared publicationsAnnemarie Hübers
University of Ulm, Neurology Clinic, Ulm, Germany
2 shared publications- Aylin Domaniku
Department of Clinical Neuroscience, Karolinska Institute, Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden
2 shared publications Caroline Ingre
Department of Neurology, Karolinska University Hospital, Stockholm, Sweden
2 shared publications
Latest Publications
- Open Access
- 13 March 2025
- Published by PubPub
Ten tales of reproducibility
The OSIRIS project identified cases of notable, innovative, and inspiring reproducibility practices which advance research institutions, funders, and publishers towards reproducible research.
- 13 March 2025
- Published by PubPub
Open AccessTen tales of reproducibility
The OSIRIS project identified cases of notable, innovative, and inspiring reproducibility practices which advance research institutions, funders, and publishers towards reproducible research.
- 2 June 2021
- Published by Springer Nature in Nature Medicine
- Vol. 27 (7) , 1308
Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onset
- 2 June 2021
- Published by Springer Nature in Nature Medicine
- Vol. 27 (7) , 1308
Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onset
- 15 April 2021
- Published by Springer Nature in Nature Medicine
- Vol. 27 (4) , 640-646
Altered perivascular fibroblast activity precedes ALS disease onset
Apart from well-defined factors in neuronal cells1, only a few reports consider that the variability of sporadic amyotrophic lateral sclerosis (ALS) progression can depend on less-defined contributions from glia2,3 and blood vessels4. In this study we use an expression-weighted cell-type enrichment method to infer cell activity in spinal cord samples from patients with sporadic ALS and mouse models of this disease. Here we report that patients with sporadic ALS present cell activity patterns consistent with two mouse models in which enrichments of vascular cell genes preceded microglial response. Notably, during the presymptomatic stage, perivascular fibroblast cells showed the strongest gene enrichments, and their marker proteins SPP1 and COL6A1 accumulated in enlarged perivascular spaces in patients with sporadic ALS. Moreover, in plasma of 574 patients with ALS from four independent cohorts, increased levels of SPP1 at disease diagnosis repeatedly predicted shorter survival with stronger effect than the established risk factors of bulbar onset or neurofilament levels in cerebrospinal fluid. We propose that the activity of the recently discovered perivascular fibroblast can predict survival of patients with ALS and provide a new conceptual framework to re-evaluate definitions of ALS etiology.
- 15 April 2021
- Published by Springer Nature in Nature Medicine
- Vol. 27 (4) , 640-646
Altered perivascular fibroblast activity precedes ALS disease onset
Apart from well-defined factors in neuronal cells1, only a few reports consider that the variability of sporadic amyotrophic lateral sclerosis (ALS) progression can depend on less-defined contributions from glia2,3 and blood vessels4. In this study we use an expression-weighted cell-type enrichment method to infer cell activity in spinal cord samples from patients with sporadic ALS and mouse models of this disease. Here we report that patients with sporadic ALS present cell activity patterns consistent with two mouse models in which enrichments of vascular cell genes preceded microglial response. Notably, during the presymptomatic stage, perivascular fibroblast cells showed the strongest gene enrichments, and their marker proteins SPP1 and COL6A1 accumulated in enlarged perivascular spaces in patients with sporadic ALS. Moreover, in plasma of 574 patients with ALS from four independent cohorts, increased levels of SPP1 at disease diagnosis repeatedly predicted shorter survival with stronger effect than the established risk factors of bulbar onset or neurofilament levels in cerebrospinal fluid. We propose that the activity of the recently discovered perivascular fibroblast can predict survival of patients with ALS and provide a new conceptual framework to re-evaluate definitions of ALS etiology.